Pall Corporation And SOTAX Corporation Deliver Cost-Effective Automation Certified Solutions For Automated Pharmaceutical Testing Systems

Published: Mar 19, 2010

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation, (NYSE: PLL), a global leader in filtration, separation and purification, has announced a long-term joint marketing agreement with SOTAX Group that will include Pall Acrodisc® PSF syringe filters in all SOTAX dissolution systems for solid dosage forms. The exclusive agreement is the initial step that allows the companies to begin delivering complete certification solutions that save time and testing costs for quality control laboratories.

Back to news